Literature DB >> 22056401

Can we combine symptom scales for collaborative research projects?

John P Lyne1, Anthony Kinsella, Brian O'Donoghue.   

Abstract

Collaborative research projects have the potential to answer important research questions, which may otherwise require huge resources, funding, and time to complete. There are several scales for measuring psychotic symptoms in schizophrenia and other psychotic disorders, with the Scale for Assessment of Positive Symptoms (SAPS), Scale for Assessment of Negative Symptoms (SANS), Positive and Negative Symptom Scale (PANSS), and the Brief Psychiatric Rating Scale (BPRS) being among the most commonly used. High quality research efforts have used these three scales in different projects, and in order to merge study efforts, some means of combining data from these scales may be necessary. We reviewed correlations in published studies for these three scales, finding them to be highly correlated, however on comparison of the three scales there were considerable clinical differences between them. The paper discusses potential methods for combining the scales in collaborative research, including use of the recently developed standardised remission criteria for schizophrenia.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22056401     DOI: 10.1016/j.jpsychires.2011.10.002

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  12 in total

1.  Proximal Risk Factors for Short-Term Community Violence Among Adults With Mental Illnesses.

Authors:  Kiersten L Johnson; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Marvin S Swartz; Richard A Van Dorn
Journal:  Psychiatr Serv       Date:  2016-02-29       Impact factor: 3.084

2.  Converting positive and negative symptom scores between PANSS and SAPS/SANS.

Authors:  Theo G M van Erp; Adrian Preda; Dana Nguyen; Lawrence Faziola; Jessica Turner; Juan Bustillo; Aysenil Belger; Kelvin O Lim; Sarah McEwen; James Voyvodic; Daniel H Mathalon; Judith Ford; Steven G Potkin
Journal:  Schizophr Res       Date:  2013-12-11       Impact factor: 4.939

3.  Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.

Authors:  Daniel Fulford; Rahel Pearson; Barbara K Stuart; Melissa Fisher; Daniel H Mathalon; Sophia Vinogradov; Rachel L Loewy
Journal:  Psychiatry Res       Date:  2014-08-01       Impact factor: 3.222

4.  Effects of sample size and distributional assumptions on competing models of the factor structure of the PANSS and BPRS.

Authors:  Stephen J Tueller; Kiersten L Johnson; Kevin J Grimm; Sarah L Desmarais; Brian G Sellers; Richard A Van Dorn
Journal:  Int J Methods Psychiatr Res       Date:  2016-12-02       Impact factor: 4.035

5.  The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.

Authors:  Richard A Van Dorn; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Kiersten L Johnson; Brian G Sellers; Marvin S Swartz
Journal:  Psychiatry Res       Date:  2016-08-09       Impact factor: 3.222

6.  A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.

Authors:  Adrian Preda; Dana D Nguyen; Juan R Bustillo; Aysenil Belger; Daniel S O'Leary; Sarah McEwen; Shichun Ling; Lawrence Faziola; Daniel H Mathalon; Judith M Ford; Steven G Potkin; Theo G M van Erp
Journal:  Schizophr Res       Date:  2018-06-20       Impact factor: 4.939

7.  Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis.

Authors:  Cota Navin Gupta; Vince D Calhoun; Srinivas Rachakonda; Jiayu Chen; Veena Patel; Jingyu Liu; Judith Segall; Barbara Franke; Marcel P Zwiers; Alejandro Arias-Vasquez; Jan Buitelaar; Simon E Fisher; Guillen Fernandez; Theo G M van Erp; Steven Potkin; Judith Ford; Daniel Mathalon; Sarah McEwen; Hyo Jong Lee; Bryon A Mueller; Douglas N Greve; Ole Andreassen; Ingrid Agartz; Randy L Gollub; Scott R Sponheim; Stefan Ehrlich; Lei Wang; Godfrey Pearlson; David C Glahn; Emma Sprooten; Andrew R Mayer; Julia Stephen; Rex E Jung; Jose Canive; Juan Bustillo; Jessica A Turner
Journal:  Schizophr Bull       Date:  2014-12-28       Impact factor: 9.306

8.  Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia.

Authors:  Mario Quarantelli; Olga Palladino; Anna Prinster; Vittorio Schiavone; Barbara Carotenuto; Arturo Brunetti; Angela Marsili; Margherita Casiello; Giovanni Muscettola; Marco Salvatore; Andrea de Bartolomeis
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

9.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

Review 10.  Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.

Authors:  Kate Merritt; Philip McGuire; Alice Egerton
Journal:  Front Psychiatry       Date:  2013-11-26       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.